These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

669 related articles for article (PubMed ID: 25529996)

  • 1. The therapeutic monoclonal antibody market.
    Ecker DM; Jones SD; Levine HL
    MAbs; 2015; 7(1):9-14. PubMed ID: 25529996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody: the corner stone of modern biotherapeutics.
    Xia ZN; Cai XT; Cao P
    Yao Xue Xue Bao; 2012 Oct; 47(10):1275-80. PubMed ID: 23289138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 'Biosimilar' drugs poised to penetrate market.
    Ledford H
    Nature; 2010 Nov; 468(7320):18-9. PubMed ID: 21048737
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current situations and the future prospect of monoclonal antibody products].
    Yamaguchi T
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2014; (132):36-46. PubMed ID: 25707201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tysabri back on market.
    Sheridan C
    Nat Biotechnol; 2006 Aug; 24(8):874. PubMed ID: 16900111
    [No Abstract]   [Full Text] [Related]  

  • 6. The therapeutic antibodies market to 2008.
    Pavlou AK; Belsey MJ
    Eur J Pharm Biopharm; 2005 Apr; 59(3):389-96. PubMed ID: 15760719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphoma market turf war imminent, pending Bexxar approval.
    Garber K
    Nat Biotechnol; 2003 Feb; 21(2):115-6. PubMed ID: 12560823
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibodies to watch in 2020.
    Kaplon H; Muralidharan M; Schneider Z; Reichert JM
    MAbs; 2020; 12(1):1703531. PubMed ID: 31847708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cumulative updating of approved biopharmaceuticals.
    Redwan el-RM
    Hum Antibodies; 2007; 16(3-4):137-58. PubMed ID: 18334749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody "gold rush".
    Maggon K
    Curr Med Chem; 2007; 14(18):1978-87. PubMed ID: 17691940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New frontiers in oncology: biosimilar monoclonal antibodies for the treatment of breast cancer.
    Thill M
    Expert Rev Anticancer Ther; 2015 Mar; 15(3):331-8. PubMed ID: 25539719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [From orthoclone to denosumab, the fast growing market of monoclonal antibodies].
    Biot J; Fasano C; Dos Santos C
    Med Sci (Paris); 2009 Dec; 25(12):1177-82. PubMed ID: 20035702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies market.
    Reichert J; Pavolu A
    Nat Rev Drug Discov; 2004 May; 3(5):383-4. PubMed ID: 15152631
    [No Abstract]   [Full Text] [Related]  

  • 14. Marketed therapeutic antibodies compendium.
    Reichert JM
    MAbs; 2012; 4(3):413-5. PubMed ID: 22531442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guardians at the gate: patent protection of therapeutic monoclonal antibodies through product life cycle management--Part 3.
    McCabe KW; Calvo PA
    MAbs; 2009; 1(6):600-3. PubMed ID: 20068401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biosimilar monoclonal antibodies: A Canadian regulatory perspective on the assessment of clinically relevant differences and indication extrapolation.
    Scott BJ; Klein AV; Wang J
    J Clin Pharmacol; 2015 Mar; 55 Suppl 3():S123-32. PubMed ID: 24965228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. StatBite: Avastin Quarterly Sales, 2009-2011.
    J Natl Cancer Inst; 2011 Aug; 103(15):1149. PubMed ID: 21768533
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of therapeutic antibodies for the treatment of diseases.
    Lu RM; Hwang YC; Liu IJ; Lee CC; Tsai HZ; Li HJ; Wu HC
    J Biomed Sci; 2020 Jan; 27(1):1. PubMed ID: 31894001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The challenge of integrating monoclonal antibodies into the current healthcare system.
    Brixner DI; Bull SA
    Am J Manag Care; 1997 Jun; 3(6):903-11. PubMed ID: 10170294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibody therapeutics: history and future.
    Buss NA; Henderson SJ; McFarlane M; Shenton JM; de Haan L
    Curr Opin Pharmacol; 2012 Oct; 12(5):615-22. PubMed ID: 22920732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.